A phase II study of pembrolizumab and mogamulizumab in advanced-stage, relapsed/refractory cutaneous T-cell lymphomas

Status: Open to Accrual

Learn more: 

• https://clinicaltrials.gov/study/NCT05956041

Study Contact: studies@hoosiercancer.org; (317) 921-2050.